The Trend of Scientific Productions on the Use of Herbal Medicines in Metabolic Disorders in the Middle East Countries Publisher



Malazy OT^{1, 2} ; Nikfar S^{2, 3, 4, 5} ; Abdollahi M^{6, 7} ; Larijani B² Show Affiliations
Source: Jundishapur Journal of Natural Pharmaceutical Products Published:2021

Abstract

Context: Prevalence of metabolic disorders, type 2 diabetes mellitus (T2DM), dyslipidemia, obesity, metabolic syndrome (MetS), and osteoporosis has been increased. Herbal medicine is an accessible, safe, and low-cost option in managing and caring for metabolic disorders. We conducted a bibliometric analysis of global scientific productions in herbal medications and metabolic disorders in the Middle East countries. Study Selection: Our search terms were diabetes, dyslipidemia, obesity, osteoporosis, metabolic syndrome, herb, and herbal medicine in Middle East countries through the Scopus database until January 2020. We analyzed the data regarding publication year, main journal, geographical distribution, document type, subject area, co-Authorship network, the h-index of citations by Scopus analysis tools, Visualizing Scientific Landscapes (VOSviewer) version 1.6.4, and SPSS version 15. Results: Among 6408 global publications, most of the papers (85%) were original articles, and mostly (44.26%) were about dyslipidemia. A significant time-Trend was shown in the number of documents (P 0.001), mostly in 2019. Medicine and pharmacology were subject areas in 80% of papers. The top country in the global publication number was Iran. The highest cited papers in dyslipidemia, obesity and osteoporosis were original articles from Turkey and Egypt, but in T2DM and MetS the highest cited paper was a review article from Iran. The top sources were Phytotherapy Research and the Journal of Ethnopharmacology. The top institutes were from Egypt, Iran, and Saudi Arabia and the principal author in the co-Authorship network assessment was from Iran. Conclusions: The time-Trend growth in producing scholarly papers in the studied disorders is appreciated, but more evidencebased articles are still needed. © 2021 Kowsar Medical Publishing Company. All rights reserved.